Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT05889546
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biospecimen Collection — PROCEDURE
    Lung, liver, skin, subcutaneous metastases, and blood specimens may be collected via rapid autopsy within 10 hours of expiration.

Study Details

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

Key Dates

Start date
Aug 31, 2022
Status verified
Jul 2025
Primary completion
Dec 31, 2030
Completion
Dec 31, 2031

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Active SCLC Diagnosis

Primary Outcome Measure

Determining the Feasibility of the Creation of a Rapid Autopsy Program at IUSCCC for SCLC through enrollment and sample collections [ Time Frame: 5 years ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolisIndiana46202
Gabby Kline, BA
[email protected]
317-278-2514
Shadia I. Jalal, MD
[email protected]
317-274-3589
Roudebush VA Medical CenterIndianapolisIndiana46202
Cynthia Johnson
[email protected]
317-278-7403
Shadia Jalal, MD
[email protected]
317-274-3589
Sidney and Lois Eskenazi HospitalIndianapolisIndiana46202
Gaby Kline, BA
[email protected]
317-278-2514
Shadia I. Jalal, MD
[email protected]
317-274-3589

Find similar trials in Indianapolis, IN

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Indiana University Melvin and Bren Simon Comprehensive Cancer Center· Indianapolis, INRoudebush VA Medical Center· Indianapolis, INSidney and Lois Eskenazi Hospital· Indianapolis, IN

Related Studies